Principal Financial Group’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7M Sell
519,130
-139,306
-21% -$4.51M 0.01% 1066
2025
Q4
$22.9M Buy
658,436
+247,027
+60% +$8.72M 0.01% 813
2025
Q3
$14.9M Sell
411,409
-43,510
-10% -$1.48M 0.01% 1033
2025
Q2
$14.3M Sell
454,919
-23,945
-5% -$744K 0.01% 1052
2025
Q1
$14.2M Sell
478,864
-23,993
-5% -$720K 0.01% 1055
2024
Q4
$14.8M Sell
502,857
-43,461
-8% -$1.37M 0.01% 1054
2024
Q3
$17M Buy
546,318
+109,206
+25% +$3.97M 0.01% 940
2024
Q2
$14.8M Sell
437,112
-80,092
-15% -$4.08M 0.01% 1044
2024
Q1
$33.6M Buy
517,204
+33,868
+7% +$2.32M 0.02% 627
2023
Q4
$33M Sell
483,336
-2,550
-0.5% -$133K 0.02% 593
2023
Q3
$25.2M Buy
485,886
+2,129
+0.4% +$126K 0.02% 686
2023
Q2
$29M Buy
483,757
+29,953
+7% +$1.71M 0.02% 637
2023
Q1
$22.4M Sell
453,804
-48,179
-10% -$2.71M 0.02% 780
2022
Q4
$28.6M Sell
501,983
-24,269
-5% -$1.37M 0.02% 620
2022
Q3
$24.7M Buy
526,252
+226,302
+75% +$10.8M 0.02% 646
2022
Q2
$11.2M Buy
299,950
+64,405
+27% +$2.09M 0.01% 1190
2022
Q1
$7.04M Buy
235,545
+1,106
+0.5% +$27.9K ﹤0.01% 1524
2021
Q4
$8.03M Buy
234,439
+49,514
+27% +$1.79M ﹤0.01% 1504
2021
Q3
$6.86M Buy
184,925
+7,820
+4% +$264K ﹤0.01% 1568
2021
Q2
$6.92M Buy
177,105
+53,533
+43% +$2.07M ﹤0.01% 1609
2021
Q1
$5.26M Buy
+123,572
New +$5.5M ﹤0.01% 1652

Other funds holding IMCR